Open-label study in healthy subjects evaluating steady-state pharmacokinetic interactions between daclatasvir and atazanavir/ritonavir

Trial Profile

Open-label study in healthy subjects evaluating steady-state pharmacokinetic interactions between daclatasvir and atazanavir/ritonavir

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Aug 2013

At a glance

  • Drugs Daclatasvir (Primary) ; Atazanavir/ritonavir
  • Indications Hepatitis C; HIV infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 16 Mar 2012 New trial record
    • 08 Mar 2012 Data were presented at the 19th Conference on Retroviruses and Opportunistic Infections (CROI) [Poster Number 618], according to a Bristol-Myers Squibb media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top